Report Detail
Global Passive Transdermal Drug Delivery Market Research Report 2019
- RnM2745099 |
- 09 January, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
This report studies the global Passive Transdermal Drug Delivery market status and forecast, categorizes the global Passive Transdermal Drug Delivery market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Microfluidics
Smart Pill Technology (SPT)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Others
The study objectives of this report are:
To analyze and study the global Passive Transdermal Drug Delivery capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Passive Transdermal Drug Delivery manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Passive Transdermal Drug Delivery are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Passive Transdermal Drug Delivery Manufacturers
Passive Transdermal Drug Delivery Distributors/Traders/Wholesalers
Passive Transdermal Drug Delivery Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Passive Transdermal Drug Delivery market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Passive Transdermal Drug Delivery Market Research Report 2018
1 Passive Transdermal Drug Delivery Market Overview
- 1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
- 1.2 Passive Transdermal Drug Delivery Segment by Type (Product Category)
- 1.2.1 Global Passive Transdermal Drug Delivery Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
- 1.2.2 Global Passive Transdermal Drug Delivery Production Market Share by Type (Product Category) in 2017
- 1.2.3 Microfluidics
- 1.2.3 Smart Pill Technology (SPT)
- 1.3 Global Passive Transdermal Drug Delivery Segment by Application
- 1.3.1 Passive Transdermal Drug Delivery Consumption (Sales) Comparison by Application (2013-2025)
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global Passive Transdermal Drug Delivery Market by Region (2013-2025)
- 1.4.1 Global Passive Transdermal Drug Delivery Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
- 1.4.2 North America Status and Prospect (2013-2025)
- 1.4.3 Europe Status and Prospect (2013-2025)
- 1.4.4 China Status and Prospect (2013-2025)
- 1.4.5 Japan Status and Prospect (2013-2025)
- 1.4.6 Southeast Asia Status and Prospect (2013-2025)
- 1.4.7 India Status and Prospect (2013-2025)
- 1.5 Global Market Size (Value) of Passive Transdermal Drug Delivery (2013-2025)
- 1.5.1 Global Passive Transdermal Drug Delivery Revenue Status and Outlook (2013-2025)
- 1.5.2 Global Passive Transdermal Drug Delivery Capacity, Production Status and Outlook (2013-2025)
2 Global Passive Transdermal Drug Delivery Market Competition by Manufacturers
- 2.1 Global Passive Transdermal Drug Delivery Capacity, Production and Share by Manufacturers (2013-2018)
- 2.1.1 Global Passive Transdermal Drug Delivery Capacity and Share by Manufacturers (2013-2018)
- 2.1.2 Global Passive Transdermal Drug Delivery Production and Share by Manufacturers (2013-2018)
- 2.2 Global Passive Transdermal Drug Delivery Revenue and Share by Manufacturers (2013-2018)
- 2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2013-2018)
- 2.4 Manufacturers Passive Transdermal Drug Delivery Manufacturing Base Distribution, Sales Area and Product Type
- 2.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
- 2.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
- 2.5.2 Passive Transdermal Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Passive Transdermal Drug Delivery Capacity, Production, Revenue (Value) by Region (2013-2018)
- 3.1 Global Passive Transdermal Drug Delivery Capacity and Market Share by Region (2013-2018)
- 3.2 Global Passive Transdermal Drug Delivery Production and Market Share by Region (2013-2018)
- 3.3 Global Passive Transdermal Drug Delivery Revenue (Value) and Market Share by Region (2013-2018)
- 3.4 Global Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.5 North America Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.6 Europe Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.7 China Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.8 Japan Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.9 Southeast Asia Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.10 India Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Passive Transdermal Drug Delivery Supply (Production), Consumption, Export, Import by Region (2013-2018)
- 4.1 Global Passive Transdermal Drug Delivery Consumption by Region (2013-2018)
- 4.2 North America Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
- 4.3 Europe Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
- 4.4 China Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
- 4.5 Japan Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
- 4.6 Southeast Asia Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
- 4.7 India Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
5 Global Passive Transdermal Drug Delivery Production, Revenue (Value), Price Trend by Type
- 5.1 Global Passive Transdermal Drug Delivery Production and Market Share by Type (2013-2018)
- 5.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2013-2018)
- 5.3 Global Passive Transdermal Drug Delivery Price by Type (2013-2018)
- 5.4 Global Passive Transdermal Drug Delivery Production Growth by Type (2013-2018)
6 Global Passive Transdermal Drug Delivery Market Analysis by Application
- 6.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Application (2013-2018)
- 6.2 Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2013-2018)
- 6.3 Market Drivers and Opportunities
- 6.3.1 Potential Applications
- 6.3.2 Emerging Markets/Countries
7 Global Passive Transdermal Drug Delivery Manufacturers Profiles/Analysis
- 7.1 3M
- 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.1.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.1.2.1 Product A
- 7.1.2.2 Product B
- 7.1.3 3M Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.1.4 Main Business/Business Overview
- 7.2 Actavis, Inc.
- 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.2.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.2.2.1 Product A
- 7.2.2.2 Product B
- 7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.2.4 Main Business/Business Overview
- 7.3 Bayer AG
- 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.3.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.3.2.1 Product A
- 7.3.2.2 Product B
- 7.3.3 Bayer AG Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.3.4 Main Business/Business Overview
- 7.4 Boehringer Ingelheim GmbH
- 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.4.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.4.2.1 Product A
- 7.4.2.2 Product B
- 7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.4.4 Main Business/Business Overview
- 7.5 Corium International, Inc.
- 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.5.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.5.2.1 Product A
- 7.5.2.2 Product B
- 7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
- 7.5.4 Main Business/Business Overview
- 7.6 Echo Therapeutics, Inc.
- 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.6.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.6.2.1 Product A
- 7.6.2.2 Product B
- 7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.6.4 Main Business/Business Overview
- 7.7 GlaxoSmithKline plc
- 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.7.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.7.2.1 Product A
- 7.7.2.2 Product B
- 7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.7.4 Main Business/Business Overview
- 7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
- 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.8.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.8.2.1 Product A
- 7.8.2.2 Product B
- 7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.8.4 Main Business/Business Overview
- 7.9 Mylan N.V.
- 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.9.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.9.2.1 Product A
- 7.9.2.2 Product B
- 7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.9.4 Main Business/Business Overview
- 7.8 Novartis AG
- 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.10.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
- 7.10.2.1 Product A
- 7.10.2.2 Product B
- 7.10.3 Novartis AG Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.10.4 Main Business/Business Overview
- 7.11 Noven Pharmaceuticals, Inc.
- 7.12 Transdermal Corp.
8 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
- 8.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.1.4 Market Concentration Rate of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.2.1 Raw Materials
- 8.2.2 Labor Cost
- 8.2.3 Manufacturing Expenses
- 8.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
- 9.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
- 9.2 Upstream Raw Materials Sourcing
- 9.3 Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
- 9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
11 Market Effect Factors Analysis
- 11.1 Technology Progress/Risk
- 11.1.1 Substitutes Threat
- 11.1.2 Technology Progress in Related Industry
- 11.2 Consumer Needs/Customer Preference Change
- 11.3 Economic/Political Environmental Change
12 Global Passive Transdermal Drug Delivery Market Forecast (2018-2025)
- 12.1 Global Passive Transdermal Drug Delivery Capacity, Production, Revenue Forecast (2018-2025)
- 12.1.1 Global Passive Transdermal Drug Delivery Capacity, Production and Growth Rate Forecast (2018-2025)
- 12.1.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
- 12.1.3 Global Passive Transdermal Drug Delivery Price and Trend Forecast (2018-2025)
- 12.2 Global Passive Transdermal Drug Delivery Production, Consumption , Import and Export Forecast by Region (2018-2025)
- 12.2.1 North America Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.2 Europe Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.3 China Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.4 Japan Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.5 Southeast Asia Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.6 India Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.3 Global Passive Transdermal Drug Delivery Production, Revenue and Price Forecast by Type (2018-2025)
- 12.4 Global Passive Transdermal Drug Delivery Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown and Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
Summary:
Get latest Market Research Reports on Passive Transdermal Drug Delivery . Industry analysis & Market Report on Passive Transdermal Drug Delivery is a syndicated market report, published as Global Passive Transdermal Drug Delivery Market Research Report 2019. It is complete Research Study and Industry Analysis of Passive Transdermal Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
